| Trial Identifier: | D8242C00001 |
| Sponsor: | AstraZeneca |
| NCTID: | NCT05205161 |
| Start Date: | July 2022 |
| Primary Completion Date: | October 2024 |
| Study Completion Date: | May 2025 |
| Condition: | Non-Hodgkin's Lymphoma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| KR | Seoul, KR, 03080 |
| KR | Seoul, KR, 03722 |
| KR | Seoul, KR, 06351 |
| KR | Seoul, KR, 6591 |
| US, CA | Duarte, CA, US, 91010 |
| US, TX | Houston, TX, US, 77030 |
| US, OH | Canton, OH, US, 44718 |
| ES | Barcelona, ES, 8035 |
| ES | Barcelona, ES, 08036 |
| ES | Madrid, ES, 28027 |
| ES | Palma de Mallorca, ES, 07010 |
| ES | Pamplona, ES, 31008 |
| ES | Salamanca, ES, 37007 |
| IT | Bologna, IT, 40138 |
| IT | PERUGIA, IT, 06132 |
| IT | Porto, IT, 4200-072 |
| IT | Roma, IT, 00144 |
| US, NC | Concord, NC, US, 28025 |
| US, MN | Rochester, MN, US, 55905 |
| CA, ON | Toronto, ON, CA, M5G 2M9 |
| FR | LILLE CEDEX, FR, 59037 |
| FR | Nantes, FR, 44000 |
| FR | Poitiers, FR, 86021 |
| PT | Lisboa, PT, 1649-035 |
| PT | Porto, PT, 4200-072 |
| AU | Greenslopes, AU, 4120 |
| AU | Heidelberg, AU, 3084 |
| US, MD | Baltimore, MD, US, 21231 |
| US, NY | Buffalo, NY, US, 14263 |
| US, VA | Richmond, VA, US, 23298 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company